Apyx Medical Corp Cash And Cash Equivalents At Carrying Value

• Apyx Medical Corp showed a decrease of 0.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2008 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $3.37 million | Q3 2010: $2.65 million | Q1 2011: $4.45 million | Q2 2011: $5.71 million | Q3 2011: $5.41 million | Q1 2012: $4.12 million | Q2 2012: $4.98 million | Q3 2012: $4.49 million | Q1 2013: $3.76 million | Q2 2013: $2.56 million | Q3 2013: $2.50 million | Q1 2014: $6.71 million | Q2 2014: $5.58 million | Q3 2014: $6.14 million | Q1 2015: $15.40 million | Q2 2015: $14.09 million | Q3 2015: $13.20 million | Q1 2016: $9.46 million | Q2 2016: $9.32 million | Q3 2016: $9.33 million | Q1 2017: $11.51 million | Q2 2017: $10.29 million | Q3 2017: $9.41 million | Q1 2018: $8.70 million | Q2 2018: $7.88 million | Q2 2019: $67.36 million | Q3 2019: $62.27 million | Q1 2020: $51.38 million | Q2 2020: $46.16 million | Q3 2020: $43.54 million | Q1 2021: $39.54 million | Q2 2021: $34.67 million | Q3 2021: $30.90 million | Q1 2022: $26.23 million | Q2 2022: $20.06 million | Q3 2022: $14.83 million | Q1 2023: $16.26 million | Q2 2023: $18.48 million | Q3 2023: $22.13 million | Q1 2024: $37.28 million | Q2 2024: $32.68 million | Q3 2024: $28.01 million | Q1 2025: $31.01 million | Q2 2025: $29.30 million | Q3 2025: $25.14 million.
• Over the full 20 years of available data (2008 to 2025), Apyx Medical Corp's Cash And Cash Equivalents At Carrying Value has grown by 1,137.9%.
• Historical annual values: Fiscal year 2025: $31.74 million | Fiscal year 2024: $31.74 million | Fiscal year 2023: $43.65 million | Fiscal year 2022: $10.19 million | Fiscal year 2021: $30.87 million | Fiscal year 2020: $41.92 million | Fiscal year 2019: $58.81 million | Fiscal year 2019: $32.42 million | Fiscal year 2018: $16.60 million | Fiscal year 2018: $40.66 million | Fiscal year 2017: $9.95 million | Fiscal year 2016: $14.46 million | Fiscal year 2015: $11.81 million | Fiscal year 2014: $5.73 million | Fiscal year 2013: $7.92 million | Fiscal year 2012: $4.16 million | Fiscal year 2011: $4.88 million | Fiscal year 2010: $3.83 million | Fiscal year 2009: $2.16 million | Fiscal year 2008: $2.56 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026